2021
DOI: 10.1007/s12264-021-00662-3
|View full text |Cite
|
Sign up to set email alerts
|

TRPV4 Regulates Soman-Induced Status Epilepticus and Secondary Brain Injury via NMDA Receptor and NLRP3 Inflammasome

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
15
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 28 publications
(15 citation statements)
references
References 43 publications
0
15
0
Order By: Relevance
“…These results suggest that TRPV4 activation promotes NFκB-NLRP3 activation and inflammation in response to pressure overload, which further demonstrates a mechanism for TRPV4 in this response. Several other studies have also found that TRPV4 activation induces inflammation through the NFκB-NLRP3 signaling pathway ( Wang et al, 2021 ; Wang et al, 2019b ). In addition, we found that GSK790A also induced rapid phosphorylation of NFκB, which could be prevented by KN-93 for CaMKII inhibition, and this implies that CaMKII is involved in TRPV4 activation-induced phosphorylation of NFκB.…”
Section: Discussionmentioning
confidence: 86%
“…These results suggest that TRPV4 activation promotes NFκB-NLRP3 activation and inflammation in response to pressure overload, which further demonstrates a mechanism for TRPV4 in this response. Several other studies have also found that TRPV4 activation induces inflammation through the NFκB-NLRP3 signaling pathway ( Wang et al, 2021 ; Wang et al, 2019b ). In addition, we found that GSK790A also induced rapid phosphorylation of NFκB, which could be prevented by KN-93 for CaMKII inhibition, and this implies that CaMKII is involved in TRPV4 activation-induced phosphorylation of NFκB.…”
Section: Discussionmentioning
confidence: 86%
“…NLRP3 inflammasome becomes a target for the prevention and treatment of central nervous system diseases. 41 , 42 The expression of NLRP3 inflammasome in BCP increased significantly in a time-dependent manner and was mainly co-localized with NeuN in SDH. 43 We found that BCP upregulated NLRP3, IL-1β, and caspase-1 expression in vitro and in vivo .…”
Section: Discussionmentioning
confidence: 99%
“…The Abx-treated Casp1 KO group demonstrated no pain behavior attenuation and less expression of the inflammation-associated nociceptors CB2, PAR2 and TRPV4. These nociceptors have been shown to regulate the inflammasome pathway in a model of brain injury and demyelination, where the deletion or inhibition of TRPV4 reduced the activation of the NLRP3 inflammasome pathway [ 35 , 36 ]. In addition, administration of CB2 agonists or PAR-2 antagonist to mice with inflammatory pain or with knee joint pain led to the reduction of NLRP3 inflammasome activation [ 37 , 38 ].…”
Section: Discussionmentioning
confidence: 99%